Apimeds engages IBN to expand investor communications across 5,000+ outlets
AI Summary- Apimeds Pharmaceuticals US engages IBN for corporate communications support.
- 5,000+ syndication outlets are included in IBN’s investor-focused distribution network.
- MindWave Innovations is developing four ecosystems under its MindChain platform.